Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares [Yahoo! Finance]
Intellia Therapeutics, Inc. (NTLA)
Last intellia therapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intelliatx.com/investor-overview
Company Research
Source: Yahoo! Finance
Leonard's direct holdings, as reported. All shares sold were from direct ownership; indirect holdings, including 58,415 shares in the John M. Leonard 2015 Irrevocable Trust, were unaffected. These 10 stocks could mint the next wave of millionaires › On Jan. 5, John M. Leonard, the president and CEO of Intellia Therapeutics (NASDAQ:NTLA) , executed an open-market sale of 34,146 directly held shares, totaling $314,484.66, as disclosed in a SEC Form 4 filing Metric Value Shares sold (direct) Transaction value Post-transaction shares (direct) Post-transaction shares (indirect) Post-transaction value (direct ownership) Transaction value based on SEC Form 4 reported price ($9.21); post-transaction value based on the SEC-reported holding and the trade-date close price. How does the size of this transaction compare to John M. Leonard's prior open-market sales? This transaction involved 34,146 shares, which is in line with other sales over the past, reinforcing a patt
Show less
Read more
Impact Snapshot
Event Time:
NTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTLA alerts
High impacting Intellia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
NTLA
News
- Fred Cohen Buys 303% More Intellia Therapeutics Shares [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Intellia Stock Declines Around 55% in 3 Months: Here's Why [Yahoo! Finance]Yahoo! Finance
- We Think Intellia Therapeutics (NASDAQ:NTLA) Needs To Drive Business Growth Carefully [Yahoo! Finance]Yahoo! Finance
NTLA
Earnings
- 11/6/25 - Beat
NTLA
Sec Filings
- 1/9/26 - Form 8-K
- 1/7/26 - Form 4
- 1/7/26 - Form 4
- NTLA's page on the SEC website